Highbridge Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-100,000
Closed -$2.24M 1620
2018
Q1
$2.24M Hold
100,000
0.06% 423
2017
Q4
$2.5M Buy
100,000
+49,177
+97% +$1.2M 0.07% 352
2017
Q3
$1.23M Buy
50,823
+40,823
+408% +$960K 0.03% 525
2017
Q2
$202K Sell
10,000
-18,345
-65% -$382K ﹤0.01% 1112
2017
Q1
$763K Sell
28,345
-10,651
-27% -$217K 0.02% 726
2016
Q4
$741K Sell
38,996
-40,227
-51% -$769K 0.02% 635
2016
Q3
$1.55M Buy
79,223
+43,646
+123% +$738K 0.03% 474
2016
Q2
$533K Sell
35,577
-28,968
-45% -$364K 0.01% 832
2016
Q1
$594K Buy
+64,545
New +$783K 0.01% 910

Other funds holding FLXN